Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosaria Sacco

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|January 14, 2020
Rebound of disease activity after fingolimod withdrawal: Immunological and gene expression profilingRosaria Sacco, Stefan Emming, Claudio Gobbi, et al.
Multiple Sclerosis International|November 30, 2013
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MSRosaria Sacco, Simona Bonavita, Fabrizio Esposito, et al.
Journal of Neurology|November 16, 2010
Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trialRosaria Sacco, Rita Bussman, Peter Oesch, et al.
Annals of Neurology|June 11, 2025
Effect of Cumulative Exposure to Ocrelizumab on Memory B-Cell Repopulation Dynamics in Multiple SclerosisGiulio Disanto, Rosaria Sacco, Giulia Mallucci, et al.
BMC Neurology|July 14, 2019
Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patientsChiara Zecca, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine|September 9, 2023
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis OpticaJennifer Jessica Eisler, Giulio Disanto, Rosaria Sacco, et al.
Plos One|May 15, 2018
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern SwitzerlandBarbara Scotti, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine|May 25, 2024
Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple SclerosisIsabella Maraffi, Giulia Mallucci, Giulio Disanto, et al.
JAMA Neurology|September 23, 2021
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple SclerosisGiulio Disanto, Rosaria Sacco, Enos Bernasconi, et al.
Frontiers in Neurology|August 30, 2021
Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain ProcessingEmanuele Pravatà, Gianna C Riccitelli, Carlo Sestieri, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|January 14, 2020
Rebound of disease activity after fingolimod withdrawal: Immunological and gene expression profilingRosaria Sacco, Stefan Emming, Claudio Gobbi, et al.
Multiple Sclerosis International|November 30, 2013
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MSRosaria Sacco, Simona Bonavita, Fabrizio Esposito, et al.
Journal of Neurology|November 16, 2010
Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trialRosaria Sacco, Rita Bussman, Peter Oesch, et al.
Annals of Neurology|June 11, 2025
Effect of Cumulative Exposure to Ocrelizumab on Memory B-Cell Repopulation Dynamics in Multiple SclerosisGiulio Disanto, Rosaria Sacco, Giulia Mallucci, et al.
BMC Neurology|July 14, 2019
Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patientsChiara Zecca, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine|September 9, 2023
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis OpticaJennifer Jessica Eisler, Giulio Disanto, Rosaria Sacco, et al.
Plos One|May 15, 2018
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern SwitzerlandBarbara Scotti, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine|May 25, 2024
Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple SclerosisIsabella Maraffi, Giulia Mallucci, Giulio Disanto, et al.
JAMA Neurology|September 23, 2021
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple SclerosisGiulio Disanto, Rosaria Sacco, Enos Bernasconi, et al.
Frontiers in Neurology|August 30, 2021
Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain ProcessingEmanuele Pravatà, Gianna C Riccitelli, Carlo Sestieri, et al.
Pageof 4